[1] |
ANNEMA W, TIETGE UJ. Regulation of reverse cholesterol transport - a comprehensive appraisal of available animal studies[J]. Nutr Metab (Lond), 2012, 9(1): 25. DOI: 10.1186/1743-7075-9-25.
|
[2] |
ETOGO-ASSE FE, VINCENT RP, HUGHES SA, et al. High density lipoprotein in patients with liver failure; relation to sepsis, adrenal function and outcome of illness[J]. Liver Int, 2012, 32(1): 128-136. DOI: 10.1111/j.1478-3231.2011.02657.x.
|
[3] |
TSAI MH, PENG YS, CHEN YC, et al. Low serum concentration of apolipoprotein A-I is an indicator of poor prognosis in cirrhotic patients with severe sepsis[J]. J Hepatol, 2009, 50(5): 906-915. DOI: 10.1016/j.jhep.2008.12.024.
|
[4] |
Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Guideline for diagnosis and treatment of liver failure(2018)[J]. J Clin Hepatol, 2019, 35(1): 38-44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.
中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2018年版)[J]. 临床肝胆病杂志, 2019, 35(1): 38-44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.
|
[5] |
Chinese Society of Hepatology, Chinese Medical Association. Chinese guidelines on the management of liver cirrhosis[J]. J Clin Hepatol, 2019, 35(11): 2408-2425. DOI: 10.3969/j.issn.1001-5256.2019.11.006.
中华医学会肝病学分会. 肝硬化诊治指南[J]. 临床肝胆病杂志, 2019, 35(11): 2408-2425. DOI: 10.3969/j.issn.1001-5256.2019.11.006.
|
[6] |
Chinese Society of Infectious Diseases, Chinese Medical Association; Chinese Society of Hepatology, Chinese Medical Association. Guidelines for the prevention and treatment of chronic hepatitis B (version 2019)[J]. J Clin Hepatol, 2019, 35(12): 2648-2669. DOI: 10.3969/j.issn.1001-5256.2019.12.007.
中华医学会肝病学分会, 中华医学会感染病学分会. 慢性乙型肝炎防治指南(2019年版)[J]. 临床肝胆病杂志, 2019, 35(12): 2648-2669. DOI: 10.3969/j.issn.1001-5256.2019.12.007.
|
[7] |
van LEEUWEN HJ, HEEZIUS EC, DALLINGA GM, et al. Lipoprotein metabolism in patients with severe sepsis[J]. Crit Care Med, 2003, 31(5): 1359-1366. DOI: 10.1097/01.CCM.0000059724.08290.51.
|
[8] |
DELGADO-COELLO B, BRIONES-ORTA MA, MACÍAS-SILVA M, et al. Cholesterol: Recapitulation of its active role during liver regeneration[J]. Liver Int, 2011, 31(9): 1271-1284. DOI: 10.1111/j.1478-3231.2011.02542.x.
|
[9] |
MANKA P, OLLIGES V, BECHMANN LP, et al. Low levels of blood lipids are associated with etiology and lethal outcome in acute liver failure[J]. PLoS One, 2014, 9(7): e102351. DOI: 10.1371/journal.pone.0102351.
|
[10] |
CHRISTOU L, PAPPAS G, FALAGAS ME. Bacterial infection-related morbidity and mortality in cirrhosis[J]. Am J Gastroenterol, 2007, 102(7): 1510-1517. DOI: 10.1111/j.1572-0241.2007.01286.x.
|
[11] |
HUANG XP, WANG Y, CHEN L, et al. Elevated serum prostaglandin E2 predicts the risk of infection in hepatitis B virus-related acute-on-chronic liver failure patients[J]. Asian Pac J Trop Med, 2017, 10(9): 916-920. DOI: 10.1016/j.apjtm.2017.08.008.
|
[12] |
KIM HY, CHANG Y, PARK JY, et al. Characterization of acute-on-chronic liver failure and prediction of mortality in Asian patients with active alcoholism[J]. J Gastroenterol Hepatol, 2016, 31(2): 427-433. DOI: 10.1111/jgh.13084.
|
[13] |
OKADA N, SANADA Y, URAHASHI T, et al. Endotoxin metabolism reflects hepatic functional reserve in end-stage liver disease[J]. Transplant Proc, 2018, 50(5): 1360-1364. DOI: 10.1016/j.transproceed.2018.01.052.
|
[14] |
WIEST R, LAWSON M, GEUKING M. Pathological bacterial translocation in liver cirrhosis[J]. J Hepatol, 2014, 60(1): 197-209. DOI: 10.1016/j.jhep.2013.07.044.
|
[15] |
SANADA Y, MIZUTA K, URAHASHI T, et al. Impact of hepatic clearance of endotoxin using endotoxin activity assay[J]. Hepatol Int, 2012, 6(4): 778-782. DOI: 10.1007/s12072-011-9289-4.
|
[16] |
CLÀRIA J, STAUBER RE, COENRAAD MJ, et al. Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure[J]. Hepatology, 2016, 64(4): 1249-1264. DOI: 10.1002/hep.28740.
|
[17] |
TRIEB M, RAINER F, STADLBAUER V, et al. HDL-related biomarkers are robust predictors of survival in patients with chronic liver failure[J]. J Hepatol, 2020, 73(1): 113-120. DOI: 10.1016/j.jhep.2020.01.026.
|
[18] |
LEVINE DM, PARKER TS, DONNELLY TM, et al. In vivo protection against endotoxin by plasma high density lipoprotein[J]. Proc Natl Acad Sci U S A, 1993, 90(24): 12040-12044. DOI: 10.1073/pnas.90.24.12040.
|
[19] |
FESSLER MB, PARKS JS. Intracellular lipid flux and membrane microdomains as organizing principles in inflammatory cell signaling[J]. J Immunol, 2011, 187(4): 1529-1535. DOI: 10.4049/jimmunol.1100253.
|